首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >Nerve-sparing class III radical hysterectomy: a modified technique to spare the pelvic autonomic nerves without compromising radicality.
【24h】

Nerve-sparing class III radical hysterectomy: a modified technique to spare the pelvic autonomic nerves without compromising radicality.

机译:保留神经的III类根治性子宫切除术:一种改良的技术,可在不损害根治性的情况下保留盆腔植物神经。

获取原文
获取原文并翻译 | 示例
           

摘要

The objectives were to describe our nerve-sparing class III radical hysterectomy technique and assess the feasibility and safety of the procedure as well as its impact on voiding function. From January to August 2005, 21 consecutive patients with FIGO stage IB-IIA cervical cancer and 1 patient with clinical stage II endometrial cancer underwent nerve-sparing radical hysterectomy with systematic pelvic lymphadenectomy. The transurethral catheter was removed on the seventh postoperative day. Then intermittent self-catheterization was performed and post-void residual urine volume (PVR) was recorded. The nerve-sparing procedure was completed successfully and safely in all of the patients. Eight (36%) and 6 (27%) patients had the PVR of < 100 ml and < 50 ml respectively at the initial removal of the catheter. On the fourteenth day, 82% and 77% of the patients had the PVR of < 100 ml and < 50 ml, respectively. The mean duration before the PVR became < 50 ml was 11.27 (5-26) days. In conclusion, the techniquedescribed in this preliminary study appears safe, adequate, and feasible in our population with satisfactory recovery of voiding function. A larger comparative study is needed on long-term urinary, bowel, and sexual function as well as recurrence and survival.
机译:目的是描述我们保留神经的III类根治性子宫切除术的技术,并评估该手术的可行性和安全性,以及其对排尿功能的影响。从2005年1月至2005年8月,连续21例FIGO IB-IIA期宫颈癌患者和1例临床II期子宫内膜癌患者接受了保留神经性根治性子宫全切除术,并进行了系统的盆腔淋巴结清扫术。术后第七天取下经尿道导管。然后进行间歇性自我导尿,并记录排尿后的残余尿量(PVR)。所有患者均成功安全地完成了保留神经的手术。初次拔出导管时,分别有8名(36%)和6名(27%)患者的PVR分别为<100 ml和<50 ml。在第14天,PVR分别为<100 ml和<50 ml的患者分别为82%和77%。 PVR <50 ml之前的平均持续时间为11.27(5-26)天。总之,这项初步研究中描述的技术在我们的人群中显示出安全,适当和可行的排尿功能恢复良好。需要就长期尿,肠和性功能以及复发和生存进行较大的比较研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号